Acknowledgements
ONCOLOGY, RECRUITMENT, DARLING
Results of this study were partially presented at the Japanese Society of Gynecologic Oncology (JSGO) Annual Meeting, Sendai, Japan, January 29–30, 2021. AbbVie and the authors thank all the trial investigators and the patients who participated in this clinical trial, as well as support for patient recruitment via patient referral service of the Japanese Gynecologic Oncology Group. Medical writing support was provided by Thayer Darling, PhD, of Aptitude Health, and funded by AbbVie.